Does eosinophilia predict clozapine induced neutropenia? (Record no. 8928227)

MARC details
000 -LEADER
fixed length control field 01387 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513104911.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199701s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0033-3158
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/BF02245622
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hummer, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19970129
245 00 - TITLE STATEMENT
Title Does eosinophilia predict clozapine induced neutropenia?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Psychopharmacology
Date of publication, distribution, etc. Mar 1996
300 ## - PHYSICAL DESCRIPTION
Extent 201-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clozapine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Eosinophilia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Haloperidol
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neutropenia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sperner-Unterweger, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kemmler, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Falk, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kurz, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oberbauer, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fleischhacker, W W
773 0# - HOST ITEM ENTRY
Title Psychopharmacology
Related parts vol. 124
-- no. 1-2
-- p. 201-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/BF02245622">https://doi.org/10.1007/BF02245622</a>
Public note Available from publisher's website

No items available.